JP2013528386A - インビトロ診断、および、インビボ画像化、診断、ならびに、治療のための細菌β−ラクタマーゼの使用 - Google Patents

インビトロ診断、および、インビボ画像化、診断、ならびに、治療のための細菌β−ラクタマーゼの使用 Download PDF

Info

Publication number
JP2013528386A
JP2013528386A JP2013513156A JP2013513156A JP2013528386A JP 2013528386 A JP2013528386 A JP 2013528386A JP 2013513156 A JP2013513156 A JP 2013513156A JP 2013513156 A JP2013513156 A JP 2013513156A JP 2013528386 A JP2013528386 A JP 2013528386A
Authority
JP
Japan
Prior art keywords
substrate
cdc
signal
imaging
xhx3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013513156A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013528386A5 (enExample
Inventor
シリーロ，ジェフリー，ディー．
サチェッティーニ，ジェームス，シー．
ラオ，ジャンホン
シエ，ヘキシン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Texas A&M University
Original Assignee
Texas A&M University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas A&M University filed Critical Texas A&M University
Publication of JP2013528386A publication Critical patent/JP2013528386A/ja
Publication of JP2013528386A5 publication Critical patent/JP2013528386A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0028—Oxazine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G01N2333/986—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides (3.5.2), e.g. beta-lactamase (penicillinase, 3.5.2.6), creatinine amidohydrolase (creatininase, EC 3.5.2.10), N-methylhydantoinase (3.5.2.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2013513156A 2010-06-04 2011-06-03 インビトロ診断、および、インビボ画像化、診断、ならびに、治療のための細菌β−ラクタマーゼの使用 Pending JP2013528386A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/802,340 US20110020240A1 (en) 2008-08-06 2010-06-04 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics
US12/802,340 2010-06-04
PCT/US2011/001018 WO2011152883A2 (en) 2010-06-04 2011-06-03 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics

Publications (2)

Publication Number Publication Date
JP2013528386A true JP2013528386A (ja) 2013-07-11
JP2013528386A5 JP2013528386A5 (enExample) 2014-07-17

Family

ID=45067221

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013513156A Pending JP2013528386A (ja) 2010-06-04 2011-06-03 インビトロ診断、および、インビボ画像化、診断、ならびに、治療のための細菌β−ラクタマーゼの使用

Country Status (10)

Country Link
US (1) US20110020240A1 (enExample)
EP (1) EP2585611A4 (enExample)
JP (1) JP2013528386A (enExample)
KR (1) KR20130132722A (enExample)
CN (1) CN103038359A (enExample)
AU (1) AU2011262374A1 (enExample)
CA (1) CA2801299A1 (enExample)
RU (1) RU2012157279A (enExample)
WO (1) WO2011152883A2 (enExample)
ZA (1) ZA201300050B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104697970A (zh) * 2015-03-17 2015-06-10 华中科技大学同济医学院附属协和医院 一种三维重建观察细胞在载体内增殖分布的方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050227309A1 (en) * 2004-01-21 2005-10-13 Corry Schuyler B Optically-detectable enzyme substrates and their method of use
EP2823050B1 (en) * 2012-03-08 2017-03-01 Julius-Maximilians-Universität Würzburg Diagnostic chewing gum for pathogens
CN102633742A (zh) * 2012-03-22 2012-08-15 盛世泰科生物医药技术(苏州)有限公司 一种2-(6-羟基苯并[d]噻唑-2-基)噻唑-4-羧酸钠的合成方法
CN103360385A (zh) * 2012-04-06 2013-10-23 上海交通大学医学院附属第三人民医院 一种治疗mrsa感染的化合物和药物
US9677112B2 (en) * 2012-05-15 2017-06-13 The Texas A&M University System β-lactamase substrates and methods of their use for the diagnosis of tuberculosis
US11268958B2 (en) 2012-09-14 2022-03-08 The Johns Hopkins University Bacteria-specific labeled substrtates as imaging biomarkers to diagnose, locate, and monitor infections
CN104714006B (zh) * 2015-02-04 2017-10-20 国家纳米科学中心 一种检测奶制品中β‑内酰胺酶的方法
CN107703130A (zh) * 2017-09-19 2018-02-16 淮海工学院 适用于检测牛奶中残留的β‑内酰胺酶的色差检测方法
CN110551497B (zh) * 2019-09-15 2022-06-10 四川农业大学 一种分子印迹量子点磷光探针的制备方法及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010016911A2 (en) * 2008-08-06 2010-02-11 The Texas A & M University System Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407957A (en) * 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
US5338843A (en) * 1992-01-30 1994-08-16 Becton, Dickinson And Company Fluorogenic and chromogenic β-lactamase substrates
US7427680B2 (en) * 2001-01-12 2008-09-23 The Regents Of The University Of California Fluorogenic substrates for BETA-lactamase gene expression
US6166231A (en) * 1998-12-15 2000-12-26 Martek Biosciences Corporation Two phase extraction of oil from biomass
SE0302840D0 (sv) * 2003-10-29 2003-10-29 Affibody Ab Detection method
US20070048848A1 (en) * 2005-08-25 2007-03-01 Sunsource Industries Method, apparatus and system for biodiesel production from algae

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010016911A2 (en) * 2008-08-06 2010-02-11 The Texas A & M University System Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6015022948; 結核 第７４巻、第５号, ４４７〜４５２頁 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104697970A (zh) * 2015-03-17 2015-06-10 华中科技大学同济医学院附属协和医院 一种三维重建观察细胞在载体内增殖分布的方法

Also Published As

Publication number Publication date
WO2011152883A3 (en) 2012-03-29
CA2801299A1 (en) 2011-12-08
AU2011262374A1 (en) 2013-01-24
EP2585611A2 (en) 2013-05-01
KR20130132722A (ko) 2013-12-05
WO2011152883A2 (en) 2011-12-08
EP2585611A4 (en) 2013-12-04
RU2012157279A (ru) 2014-07-20
ZA201300050B (en) 2013-09-25
CN103038359A (zh) 2013-04-10
US20110020240A1 (en) 2011-01-27

Similar Documents

Publication Publication Date Title
RU2520661C2 (ru) Применение бактериальной бета-лактамазы для диагностики in vitro и визуализации, диагностики и лечения in vivo
JP2013528386A (ja) インビトロ診断、および、インビボ画像化、診断、ならびに、治療のための細菌β−ラクタマーゼの使用
Huang et al. Recent progress in fluorescent probes for bacteria
Peukert et al. Enzyme‐activated, chemiluminescent siderophore‐dioxetane probes enable the selective and highly sensitive detection of bacterial pathogens
Wang et al. Small-molecule fluorescent probes: big future for specific bacterial labeling and infection detection
Luo et al. Recent Advances in the Development of Optical Imaging Probes for γ‐Glutamyltranspeptidase
Wu et al. Rapid differentiation between bacterial infections and cancer using a near-infrared fluorogenic probe
Yeh et al. Identification of factors complicating bioluminescence imaging
US20160376629A1 (en) Use of Bacterial Beta-Lactamase for In Vitro Diagnostics and In Vivo Imaging, Diagnostics and Therapeutics
US9138490B2 (en) Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics
Yang et al. Real-time imaging of Mycobacterium tuberculosis using a novel near-infrared fluorescent substrate
Muir et al. Activity-based diagnostics: recent advances in the development of probes for use with diverse detection modalities
JP6754531B2 (ja) インビトロおよびインビボにおいてグラム陰性菌を検出するための分子プローブ
Valverde-Pozo et al. Detection by fluorescence microscopy of N-aminopeptidases in bacteria using an ICT sensor with multiphoton excitation: Usefulness for super-resolution microscopy
US20060073529A1 (en) Luciferyl peptide substrate
Trousil et al. Fluorescence & bioluminescence in the quest for imaging, probing & analysis of mycobacterial infections
JP2018501780A (ja) インビトロおよびインビボにおいて細菌および／または真菌を検出するための蛍光多分岐プローブ
KR20210054280A (ko) 이중 인식 이광자 형광 프로브 및 이의 용도
Kim et al. Development of dual reporter imaging system for Francisella tularensis to monitor the spatio-temporal pathogenesis and vaccine efficacy
WO2004038039A2 (en) Optical imagiong of renilla luciferase reporter gene expression in living organisms
Liyanage et al. Azide-Masked and Trehalose-based Fluorescence Turn-On Probe for Mycobacteria
Oryaşın Bioluminescence Based Minimal Inhibitory Concentration (MIC) Determination for Biofilm Forming Bacteria
Shinde et al. Photoproteins as in Vivo Indicators of Biological Function
Contag et al. Non-invasive monitoring of infection and gene expression in living animal models

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130418

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130509

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140530

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140530

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150610

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150907

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20151006

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20151109

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160224